Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa

E P Owen1, F Leisegang, A Whitelaw

  • 1Division of Chemical Pathology, Department of Clinical Laboratory Sciences, University of Cape Town. tricia.owen@uct.ac.za

Abstract

Insights

Complement component deficiencies, specifically C5D and C6Q0, are not rare in South Africa and increase the risk of invasive meningococcal disease (MD). Testing for these genetic conditions is recommended for all MD patients, especially in Black populations.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Invasive meningococcal disease (MD) is endemic in South Africa, with seasonal peaks.
  • Deficiencies in complement components C5 (C5D) or C6 (C6Q0) significantly elevate the risk of recurrent and severe MD.
  • MD can result in fatal outcomes or severe long-term health consequences.

Purpose of the Study:

  • To investigate the prevalence of specific C5 and C6 gene mutations in patients diagnosed with invasive MD in the Western Cape, South Africa.
  • To assess the frequency of complement component deficiencies (C5D, C6Q0) in patients with invasive meningococcal disease.

Main Methods:

  • Genetic analysis of C5 and C6 genes in 109 patients with confirmed invasive MD.
  • Stratification of results based on patient ethnicity (Black and Coloured populations).
  • Follow-up of deficient patients to offer prophylactic treatment.

Main Results:

  • Out of 109 patients, 14 (12.8%) exhibited complement deficiencies: 3 with C5D and 11 with C6Q0.
  • Among 46 Black patients, 10 (21.7%) had C5D or C6Q0.
  • Among 63 Coloured patients, 4 (6.3%) had C6Q0; none had C5D.

Conclusions:

  • Complement component deficiencies C5D and C6Q0 are relatively common in South Africa, predisposing individuals to recurrent invasive MD.
  • Black individuals in South Africa are at a higher risk, with over 21% presenting with C5D or C6Q0.
  • Routine diagnostic testing for C5 and C6 deficiency is strongly recommended for all MD cases in South Africa, with prophylactic treatment for affected individuals.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...